Total Payments
$18,168
2024 Payments
$2,158
Companies
61
Transactions
696
Medicare Patients
327
Medicare Billing
$54,850
Payment Breakdown by Category
Food & Beverage$17,806 (98.0%)
Education$362.42 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,806 | 686 | 98.0% |
| Education | $362.42 | 10 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,461 | 103 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,169 | 63 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,155 | 43 | $0 (2021) |
| Novo Nordisk Inc | $1,129 | 22 | $0 (2024) |
| PFIZER INC. | $1,039 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $977.01 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $934.26 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $835.43 | 30 | $0 (2023) |
| GlaxoSmithKline, LLC. | $711.79 | 22 | $0 (2024) |
| Amgen Inc. | $644.13 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,158 | 71 | ABBVIE INC. ($393.38) |
| 2023 | $1,707 | 63 | AbbVie Inc. ($486.12) |
| 2022 | $1,277 | 46 | ABBVIE INC. ($452.70) |
| 2021 | $1,636 | 52 | AbbVie Inc. ($547.71) |
| 2020 | $316.68 | 18 | Teva Pharmaceuticals USA, Inc. ($75.03) |
| 2019 | $2,069 | 109 | AstraZeneca Pharmaceuticals LP ($380.83) |
| 2018 | $4,189 | 166 | Teva Pharmaceuticals USA, Inc. ($758.71) |
| 2017 | $4,817 | 171 | AstraZeneca Pharmaceuticals LP ($559.01) |
All Payment Transactions
696 individual payment records from CMS Open Payments — Page 3 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $115.65 | General |
| Category: Cardio-renal | ||||||
| 04/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $105.51 | General |
| Category: DIABETES | ||||||
| 04/04/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Biological | ||||||
| 03/15/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $24.40 | General |
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.89 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Biological | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Biological | ||||||
| 02/16/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $24.40 | General |
| 02/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: Respiratory | ||||||
| 01/22/2024 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/19/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $25.31 | General |
| 01/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: Biological | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: ANTI-ANXIETY | ||||||
| 01/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $24.81 | General |
| 11/30/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 66 | 199 | $34,825 | $11,301 |
| 2022 | 2 | 73 | 178 | $30,039 | $10,684 |
| 2021 | 2 | 81 | 221 | $48,785 | $19,869 |
| 2020 | 2 | 107 | 224 | $42,586 | $12,996 |
Total Patients
327
Total Services
822
Medicare Billing
$54,850
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 199 | $34,825 | $11,301 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 152 | $24,201 | $8,489 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 26 | $5,838 | $2,194 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 209 | $46,927 | $18,967 | 40.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 12 | $1,858 | $901.68 | 48.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 115 | $25,712 | $7,014 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 109 | $16,875 | $5,982 | 35.4% |
About Dr. Vance Alm, MD
Dr. Vance Alm, MD is a Family Medicine healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578540951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vance Alm, MD has received a total of $18,168 in payments from pharmaceutical and medical device companies, with $2,158 received in 2024. These payments were reported across 696 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($17,806).
As a Medicare-enrolled provider, Alm has provided services to 327 Medicare beneficiaries, totaling 822 services with total Medicare billing of $54,850. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Reno, NV
- Active Since 12/28/2005
- Last Updated 09/02/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578540951
Products in Payments
- VRAYLAR (Drug) $1,224
- FARXIGA (Drug) $1,144
- JARDIANCE (Drug) $718.49
- XARELTO (Drug) $616.37
- ELIQUIS (Drug) $524.64
- Ozempic (Drug) $510.55
- BEVESPI AEROSPHERE (Drug) $489.09
- AJOVY (Drug) $466.82
- AUSTEDO (Drug) $460.06
- UBRELVY (Drug) $439.99
- BREZTRI (Drug) $366.98
- Synthroid (Drug) $296.06
- TRULICITY (Drug) $281.25
- SPRIX (Drug) $279.48
- TRELEGY ELLIPTA (Drug) $270.29
- CHANTIX (Drug) $268.04
- Androgel (Drug) $264.03
- MYRBETRIQ (Drug) $245.09
- Trintellix (Drug) $240.51
- Wegovy (Drug) $234.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Reno
Catherine Mccarthy, Md, MD
Family Medicine — Payments: $52,895
Family Medicine $52,895
Dr. Jeremy Bearfield, Md, Phd, MD, PHD
Family Medicine — Payments: $22,339
Family Medicine $22,339
Dr. Michael O'brien, Md, MD
Family Medicine — Payments: $22,320
Family Medicine $22,320
James Mclennan, Md Pc, MD PC
Family Medicine — Payments: $17,743
Family Medicine $17,743
Bayo Curry-Winchell, Md, MD
Family Medicine — Payments: $12,638
Family Medicine $12,638
Dr. Suraj Verma, M.d, M.D
Family Medicine — Payments: $12,462
Family Medicine $12,462